Table 1.
Clinical characteristics of healthy, gestational hypertensive, and preeclamptic pregnant women enrolled in this study.
| Parameters | HP (n = 77) | GH (n = 70) | PE (n = 76) |
|---|---|---|---|
| GA at sampling (weeks) | 36 ± 3 | 36 ± 5 | 34 ± 5 |
| Maternal age (years) | 26 ± 6 | 27 ± 7 | 28 ± 6 |
| BMI (kg/m2) | 27 ± 5 | 34 ± 5∗ | 34 ± 5∗ |
| SBP at sampling (mmHg) | 110 ± 1 | 130 ± 1∗ | 140 ± 1∗ |
| DBP at sampling (mmHg) | 74 ± 8 | 82 ± 10∗ | 82 ± 10∗ |
| GA at delivery (weeks) | 40 ± 2 | 39 ± 2 | 37 ± 4∗ |
| Newborn weight (g) | 3,255 ± 646 | 3,138 ± 554∗ | 2,644 ± 901∗ |
| α-Methyldopa at sampling (%) | NA | 70 | 88 |
| Nifedipine at sampling (%) | NA | 7 | 21 |
| Hydralazine at sampling (%) | NA | 4 | 4 |
Values are the means ± S.D. or percentage. HP: healthy pregnant; GH; gestational hypertension; PE: preeclampsia; GA: gestational age; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; NA: not applicable. ∗p < 0.05 vs. healthy pregnant.